Siekmann U, Heilmann L
Z Geburtshilfe Perinatol. 1979 Oct;183(5):351-8.
The maternal Serum concentrations of beta 1 SP 1, IgM and alpha 2-macroglobulin were determined in relation to the gestation age, using the simple radial immunodiffusion method in 102 non-pathologic pregnancies and 35 pregnancies involving risk factors. To assess the clinical relevance of these determinations, we examined to what extent the changes in concentration of beta 1 SP 1 IgM and alpha 2-macroglobulin would permit a prognostically useful conclusion on the placenta function and foetal condition. All patients with lowered beta 1 SP 1-serum concentrations were examined for their antepartua CTG-evaluation, as well as the type of termination of parturition. The normal distribution for beta 1 SP 1 showed a continuous rise in serum concentration up to the 37th pregnancy week. During the last 3 weeks, beta 1 SP 1 remained almost constant. For the cases with EPH-gestosis and placenta insufficiency, a beta 1 SP 1-concentration below the normal distribution level was found in the large majority of all cases. In diabetes mellitus during gravidity, twin gravidity and MHN, the determination of beta 1 SP 1 is not of any decisive prognostic significance. The maternal serum levels of IgM showed no significant differences when comparing normal pregnancy and risk pregnancy. The serum concentration of alpha 2-macroglobulin increased in both groups of patients with increasing gestation age. Of the three examined protein bodies, we consider beta 1 SP 1 to be a good, additional parameter for the assessment of the trophoblast function.
采用简单的放射免疫扩散法,对102例无病理妊娠和35例有危险因素的妊娠孕妇,测定其血清中β1SP1、IgM和α2-巨球蛋白的浓度,并与妊娠周数进行相关性分析。为评估这些测定结果的临床相关性,我们研究了β1SP1、IgM和α2-巨球蛋白浓度的变化在多大程度上能对胎盘功能和胎儿状况得出具有预后价值的结论。对所有β1SP1血清浓度降低的患者进行产前CTG评估以及分娩终止类型的检查。β1SP1的正常分布显示,血清浓度在妊娠第37周前持续上升。在最后3周,β1SP1几乎保持恒定。在大多数伴有EPH妊娠高血压综合征和胎盘功能不全的病例中,发现β1SP1浓度低于正常分布水平。在妊娠期糖尿病、双胎妊娠和母婴血型不合时,β1SP1的测定没有任何决定性的预后意义。比较正常妊娠和有风险妊娠时,孕妇血清IgM水平无显著差异。两组患者血清α2-巨球蛋白浓度均随妊娠周数增加而升高。在所检测的三种蛋白质中,我们认为β1SP1是评估滋养层功能的一个很好的附加参数。